Literature DB >> 28883838

Corrigendum to "Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials".

Francisco Moniche1,2, Paulo Henrique Rosado-de-Castro3, Irene Escudero1,2, Elena Zapata1,2, Francisco Javier de la Torre Laviana1,2, Rosalia Mendez-Otero4, Magdalena Carmona5, Pilar Piñero6, Alejandro Bustamante7, Lucía Lebrato1, Juan Antonio Cabezas1, Alejandro Gonzalez6, Gabriel R de Freitas8, Joan Montaner2,7.   

Abstract

[This corrects the article DOI: 10.1155/2016/8657173.].

Entities:  

Year:  2017        PMID： 28883838      PMCID： PMC5572092          DOI： 10.1155/2017/7946930

Source DB:  PubMed          Journal:  Stem Cells Int            Impact factor:   5.443


In the article titled “Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials” [1], the name of the thirteenth author was given incorrectly as Grabriel R. de Freitas. The author's name should have been written as Gabriel R. de Freitas. The revised authors' list is shown above.
  1 in total

1.  Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials.

Authors:  Francisco Moniche; Paulo Henrique Rosado-de-Castro; Irene Escudero; Elena Zapata; Francisco Javier de la Torre Laviana; Rosalia Mendez-Otero; Magdalena Carmona; Pilar Piñero; Alejandro Bustamante; Lucía Lebrato; Juan Antonio Cabezas; Alejandro Gonzalez; Grabriel R de Freitas; Joan Montaner
Journal:  Stem Cells Int       Date:  2016-07-21       Impact factor: 5.443
  1 in total
  1 in total

Review 1.  Native and Bioengineered Exosomes for Ischemic Stroke Therapy.

Authors:  Haroon Khan; Jia-Ji Pan; Yongfang Li; Zhijun Zhang; Guo-Yuan Yang
Journal:  Front Cell Dev Biol       Date:  2021-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.